- 140+ participants
- 40% of delegates boasted MD, VP, Senior Director level or higher
- 25 hours of content-driven presentations
- Over 7 hrs of dedicated networking and face-to-face time with industry leaders
› request 2010 brochure
|
Julia Santos
Director, Head of Worldwide
Strategic Outsourcing
Johnson & Johnson
Coreen Oei
VP Scientific and Clinical Operations, Virtual POC Discovery Performance Unit
GlaxoSmithKline
Janet Edwards
Director Global Clinical
Outsourcing
AstraZeneca
 Jane Clarke Assistant Vice President - EDC System Owner
Global Development Support
Wyeth Research
Dianne Kikta
Vice President, Global Clinical Strategic Resourcing
Wyeth
|
Conference:
Pre-conference workshop
2 Feb 9am - 5pm
Day 1
3 Feb 8.30am - 5:30pm
Day 2
4 Feb 8.30am - 5:30pm
Post-conference workshop
5 Feb 9am - 5pm
Location: Victoria Park Plaza, London, United Kingdom
|
|
|
|
ClinStar
|
|
ClinStar is an American CRO which manages clinical trials in Russia, Ukraine, Belarus and the Baltic States. We have more than 250 employees spread throughout our offices in Moscow, St. Petersburg, Kiev, Minsk and San Francisco. Our clients, who include many of the world’s largest Pharma companies, come to us because of our reputation for remarkable patient recruitment, quality and excellent client service.
- Patient Recruitment: ClinStar can recruit patients up to 20 times faster than is possible in Western Europe and in the US. Our clients have written many unsolicited letters describing how they were amazed by the recruitment rates that we have achieved
- Quality: Because 95% of our CRAs are MDs and because we spend more time with investigators than do other CROs, our quality is demonstrably better than that in the West and better than other CROs in Russia. The auditor for one of the world's largest biotech companies recently told us that he had never seen such good quality as he saw at ClinStar's sites in Russia and Ukraine
- Client Service: ClinStar has always maintained a simple philosophy when it comes to client service – “We keep our promises”.
Why not take the opportunity to talk with us during the conference to see how we can help you to complete your projects on time and within budget.
www.clinstar.com
|
|
DOCS International
|
|
 Our Company:
We specialise in staffing solutions for the Pharmaceutical, Biotechnology and Medical Device industries and have been a leader in our field for over fifteen years.
Our Services:
Our full-spectrum resourcing solutions extend from contingent staffing, to functional resourcing, large-scale FSP and executive search. In addition, DOCS has developed a tailored training division ‘CRAcademy’ to provide Traineeships and Training & Education programmes that are designed to develop careers for clinical research professionals.
Our Customers:
DOCS clients include small, mid and large sized Pharmaceutical companies in addition to many leading Biotechnology, Medical Device companies and CROs. As a global partner, DOCS currently offers global resourcing solutions to our clients.
Our History:
DOCS was formed in The Netherlands 1997 and grew to become the premier staffing provider to the European pharmaceutical industry. The company was acquired by ICON plc in 2007 and was merged with ICON’s existing resourcing division, ICON Contracting Solutions. The merged company is now known as DOCS, and offers clients over 15 years of experience in the provision of global resourcing solutions.
Our Scale:
With over 700 employees based in our offices in over 20 countries, DOCS offers one of the worlds broadest clinical resourcing platforms. We currently support client needs ranging from a single individual to international teams of hundreds of personnel.
www.docs-int.com
|
|
INC Research
|
|
 INC Research, a global contract research organization, uses its Trusted Process™ method of conducting Phase I – Phase IV trials so customers experience certain trial excellence, helping to minimize potential risk factors and leading to more informed and confident development decisions. With operations in 40 countries, INC Research provides experienced project teams that support oncology, CNS, respiratory, cardiovascular, infectious disease and endocrinology clinical research, as well as pediatric and women’s health trials.
www.incresearch.com
|
|
Parexel
|
|
 PAREXEL International Corporation is a leading global bio/pharmaceutical services organization committed to providing clinical operational excellence that expedites time-to-market and peak-market penetration to our partners within the worldwide pharmaceutical, biotechnology and medical device industries. PAREXEL offers significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to first-in-man through proof-of concept, clinical development, post-approval services, medical communication and reimbursement. This expertise is enhanced by advanced eClinical technology solutions, including medical imaging, Clinical Trial Management Systems (CTMS), Interactive Voice/Web Response Systems (IVRS), electronic data capture and integration services. For more information, visit www.PAREXEL.com.
|
|
LCG Bioscience
|
|
 LCG cBioscience is a fully MHRA accredited, purpose-built research facility with a 46-bed clinic. We specialise in early phase studies from First into Man through to Proof of Concept and have experience in a number of therapeutic areas both in patient groups and healthy volunteers.
Within our purpose built research unit, we have a ward for radio-isotope studies, dedicated sleep rooms and respiratory facility, clinical and biomarker laboratories, GMP pharmacy, archive and study catering facilities, allowing you to place complete studies in one location.
With additional facilities based in Harley Street, London, we offer access to a larger and more diverse pool of volunteers as well as extensive state of art imaging equipment.
LCG Bioscience biomaker facility specialises in the determination of qualitative and quantitative biomarkers using flow cytometry, immunoassay, multiplex assay and automated immunoassay systems.
We have a dedicated recruitment team and a strong volunteer database. For patient groups we have established a GP network to facilitate recruitment along with our established network of consultants.
Excellence in clinical trails since 1993. For more information go to www.lcg-bourn.co.uk
|
|
PRA International
|
|
PRA International, one of the world’s leading global clinical research organizations, conducts clinical trials in more than 65 countries across six continents. PRA provides outsourced clinical services for all therapeutic areas, across all phases of pharmaceutical and biotech drug development, with particular focus in the following therapeutic areas: Oncology and Hematology, Neurosciences (neurology and psychiatry), Cardiovascular, infectious Disease and allergy/respiratory. PRA’s therapeutic expertise, global reach and project experience, combined with extensive local knowledge and our differentiating PERSONAL ELEMENT enable our project teams to deliver consistent and on time performance for our clients.
PRA’s Early Development Services (EDS) group provides comprehensive services for Phase I and Phase IIa clinical research, bioanalytical research and data support. Our expertise is primarily with more complex types of studies in which safety and intelligent design are critical factors.
PRA’s Product Registration group has been instrumental in helping our clients conduct complex, global, multi-center trials and has supported our clients in achieving more than a dozen drug approvals across a range of therapeutic areas.
PRA’s Late Phase Services group supports global and regional Post-approval studies, assisting sponsors with the Post-Marketing process by planning and conducting Post-Authorization Safety Studies/Safety-Surveillance Studies, Drug Utilization Studies, Registries, Restricted Access Programs, Risk Evaluation and Mitigation Strategies/EU-RMP, and Diagnostic and Biomarker Research.
www.praintl.com
|
|
ClinTec International
|
|
 ClinTec International is a full service global clinical research organisation, with a presence in more than 35 developed and emerging countries, covering Western Europe, Central & Eastern Europe, Middle East and North Africa, Central and South Africa, Latin America, India and the US. In addition to ClinTec’ vast expertise in oncology, it has also conducted over a 150 clinical trials in many other therapeutic areas including anti-infectives, cardiology, dermatology, gastroenterology, neurology, respiratory medicine and rheumatology. ClinTec International excels in conducting clinical studies in diverse geographical locations, supported by a team of world class project managers, country managers and clinical research associates. ClinTec International’s ‘fast, flexible and focused’ approach to clinical research ensures an added advantage to the drug development process. ClinTec International provides clinical research resourcing services for the conduct of phase I – IV clinical trials worldwide.
www.clintec.com
|
|
Rules Based Medicine
|
|
 Rules-Based Medicine (RBM) provides comprehensive protein biomarker products and services centered on its Multi-Analyte Profiling (MAP) technology. Its service platform (RodentMAP® and HumanMAP®) provides pre-clinical and clinical researchers with reproducible, quantitative, multiplexed immunoassay data for hundreds of proteins cost-effectively in multiple species, and from a small sample volume. The testing service supports numerous GLP studies and is CLIA certified. Many of these assays are becoming available as optimized kits through our distribution partner EMD Biosciences in the Summer of 2008. The company also offers innovative and proprietary ex vivo testing systems such as TruCulture™, the first fully-closed, reproducible whole blood culture system. It is available with a MAP testing service that provides an unprecedented view of the impact of a drug compound or consumer product on an individual’s immune system without endangering a human test subject. RBM is actively developing multiplex diagnostic tests to detect the presence of complex disease and conditions in areas of unmet medical need such as neuropsychiatry, nephrology, immunology and cardiology. More information about RBM is located at www.rbmmaps.com.
|
|
Assign Group
|
|
 With constant focus on the need of our customers from the pharmaceutical and biotechnology industry, Assign Group offers tailor made solutions for the clinical development. This solution includes clinical development planning, protocol writing and full clinical study reports, feasibility studies, regulatory contacts, contracting with study sites, monitoring, project management, laboratory management, data management and eCRF, full biostatistics, IMP handling including Qualified Person. With affiliates in Austria, Germany, Hungary, Poland and Chile and a well established network of partners we provide access to well trained, motivated and experienced investigators who have a great potential of patients in Europe and South America. Assign Group staff has experience in all major therapeutic areas, which allows us to offer a broad study experience and direct knowledge of trial requirements and risk management. For further information please visit us on our homepage www. assigngroup.com or get directly in touch with the Assign Team via mail to officeINT@assigngroup.com.
|
|
Xendo
|
|
 The Clinical Pharmacology Unit of Xendo Drug Development is located in The Netherlands and operates 24 sophisticated beds. Focused on first-in-man (FIM), CNS, Pain, Imaging (PET and fMRI), Diabetes, Immunology and Female Healthcare, the unit services customers from the EU, UK, Asia and North-America. Due to the excellent regulatory climate for phase I/IIa studies in The Netherlands, Clinical Trial Approval can be obtained within 14 days.
Looking for scientific support, data management-, biometric-, clinical monitoring- or bio-analytical services, you will find the right address for a full early clinical service package at Xendo.
Being located on the campus of the University Medical Center Groningen (UMCG), Xendo collaborates with medical experts in various therapeutic areas. Our highly experienced staff of professionals is committed to provide clients with quality, timely clinical contract services while focusing on communication with clients to help them maintain project control. Xendo's Quality Assurance Department ensures the compliance of our work with Good Clinical Practice (GCP), Good Laboratory Practices (GLP), Good Manufacturing Practice (GMP) and our clients' requirements, as appropriate.
We at Xendo strive to develop long-term relationships with clients through unwavering professionalism, flexibility and attention to detail. Curious what we can do for you or looking for a budget proposal, please contact us at businessdevelopment@xendo.com or visit www.xendo.com.
|
|
Tepnel
|
|
 As the best in class global provider of analytical services to the pharmaceutical sector, Tepnel Pharmaceutical Services specialises in the provision of regulatory services and analytical solutions, including comprehensive analytical chemistry, microbiology, bioanalysis, biopharmaceuticals and genotyping under inspection and approval of the MHRA and FDA. Established for over 25 years, Tepnel Pharmaceutical Services has the experience to handle even the most complex of analytical methodologies, and is dedicated to continuously developing efficiencies on behalf of its clients. Tepnel Pharmaceutical Services is perfectly positioned to be your analytical partner of choice for all your early to late stage needs.
Meet with us at booth number 12 or join us at the speed networking event.
Tepnel Pharmaceutical Services is an established business of Gen-Probe Incorporated, a world leader in molecular diagnostics.
|
|
Chiltern
|
|
 Established in 1982, Chiltern is a leading global clinical Contract Research Organization with extensive experience conducting and staffing international Phase I to Phase IV clinical trials across a broad range of therapeutic areas for a wide variety of clients. Chiltern has conducted trials in more than 40 countries and employs 1,400 people in 29 countries. Chiltern provides Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions services. Further information is available at www.chiltern.com.
|
|
ClearTrial
|
|
 ClearTrial is the leading provider of Clinical Trial Operations (CTO) software, a seamlessly integrated system for clinical operations planning, forecasting, Sponsor/ CRO collaboration, and project tracking. ClearTrial’s award-winning software helps life sciences companies streamline their clinical operations from Plan to Cash™ without sacrificing quality of results, providing executives and functional leaders in clinical operations, resource planning, finance, outsourcing, and project management with a common platform that promotes speed, accuracy, and consistency throughout the organization. For more information please visit http://www.cleartrial.com
|
|
Barc
|
|
 BARC Global Central Laboratories offers global, dedicated support of clinical trials for the life science industries. Our network of laboratories in the Americas, Europe, Africa and Asia are committed to providing full logistical and analytical support for both routine safety testing and specialized biomarker analysis to the highest quality standards. Our wide range of technologies and high-throughput gives BARC access to a large test list with the opportunity to validate new tests through our Research & Development team.
Our laboratories offer the latest technologies and include experts in pathology, cytology, microbiology, luminex, immunoassay development, molecular biology and flow cytometric analysis. BARC has invested consistently to provide equipment that enables on-demand, automated testing for many assays that until recently would have required batch testing. This makes BARC the ideal partner for studies that range from small, single country trials to large, global programs and those that require tests from small numbers of esoteric tests to large volume safety testing.
Since the formation of BARC over 25 years ago, the focus has been on developing long-term partnerships with its clients. Client feedback consistently shows that this, together with a flexible approach, regardless of the size of the client, are key strengths of working with BARC.
www.barclab.com
|
|
Kendle
|
|
 Kendle is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the fastest-growing global providers of Phase I-IV services, we offer experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges. Kendle’s clinical development business is focused on five regions – North America, Europe, Asia/Pacific, Latin America and Africa – to meet customer needs.
Kendle's Early Stage expertise includes comprehensive global services, from First-in-Human through Phase IIa/proof-of-concept studies, with world-leading psychopharmacology expertise, in addition to bioequivalence and pharmacokinetic studies for established compounds. We have the agility to address your needs rapidly and can help you develop an optimal Early Stage plan. From initial protocol design through to regulatory submission, we can provide support at agency meetings and help you present and explain complex data.
Kendle's Early Stage units are located in Europe, Canada and the United States.
www.kendle.com
|
|
|
|
|
|
